NewsBenzingaCerenome: EPS del Q3 $(1,14) inferiore alle stime di $(0,95), ricavi a $722.000K contro stime di $920.333K Cerenome: EPS del Q3 $(1,14) inferiore alle stime di $(0,95), ricavi a $722.000K contro stime di $920.333K Benzinga 2026.11.13 22:22 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Kodiak AI, Lowers Price Target to $7 Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says